We thank Dr Corrêa and colleagues for their interest in our paper. The whole-body MR images they show from a 7-year-old child with active Camaurati-Englemann disease are certainly very striking. It would be interesting to see imaging of late-stage disease when the activity-as judged by scintigraphy-has decreased. T2-short tau inversion recovery imaging from whole-body MRI could be very useful in evaluating the effectiveness of potential medical therapies, such as angiotensin receptor blockers or glucocorticoids.
